Lv1
10 积分 2022-07-15 加入
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
18小时前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
19小时前
已完结
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
21小时前
已完结
Lenalidomide in follicular lymphoma
19天前
已完结
IBCL-378: Epcoritamab Monotherapy Demonstrates Deep and Durable Responses at 3-Year Follow-Up in Patients With Relapsed/Refractory Follicular Lymphoma
24天前
已完结
IBCL-413: Real-World Treatment Patterns and Clinical Outcomes in Patients With Marginal Zone Lymphoma
1个月前
已关闭
Gastric cancer
1个月前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
1个月前
已完结
Long-term Follow-up of Zimberelimab in Relapsed or Refractory Classic Hodgkin Lymphoma: Insights from the Phase Ⅱ YH-S001-04 Clinical Trial
2个月前
已完结
Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies
2个月前
已完结
皖公网安备34019202002308
